Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells
about
Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrestEndogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells.HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell deathHIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration.Purification and characterization of HIV-human protein complexes.Human immunodeficiency virus type 1 Vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest.Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localizationEvidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.14-3-3 theta binding to cell cycle regulatory factors is enhanced by HIV-1 VprA comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopesHIV-1 Vpr-a still "enigmatic multitasker".Defining the roles for Vpr in HIV-1-associated neuropathogenesis.HIV1-viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies.The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication.Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein functionHuman immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.The presence of the TAR RNA structure alters the programmed -1 ribosomal frameshift efficiency of the human immunodeficiency virus type 1 (HIV-1) by modifying the rate of translation initiation.Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection.Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways.Direct Vpr-Vpr interaction in cells monitored by two photon fluorescence correlation spectroscopy and fluorescence lifetime imaging.
P2860
Q27313676-10533839-B22D-4E4C-BA29-F0922A9ED317Q33490665-0FFA86E2-39DC-4121-9A87-FCC9BA5AFEECQ33614489-EC74CE64-3F26-4922-BF37-9E04C2926B4FQ33990739-1134AC4D-1FF5-4DC2-B6FF-DBD18C95D7EBQ34031619-92031694-A9DD-4CB0-8664-80F415487D52Q34348888-F61021D4-1FE7-4CED-87D9-07ECE43184C6Q34790639-7AF3824D-8463-48B7-807E-E0E928BAB4C9Q35042304-7FA8E6B7-2429-4D2E-999D-0B0777063921Q35200604-469D3E15-62DD-41D0-BB7D-B48E68A6A569Q36484010-B8836FCE-AED9-46FE-AE71-1AE79F42A161Q36665575-91986F36-22D1-42D5-9E12-7CD1249779F5Q36908259-0093198F-EDEB-4456-B604-57FB55EACAADQ37689513-1309117F-0A1D-42CB-B7DA-58A656334386Q38801550-C6BBBBBC-3885-41B4-A595-D9D3076421BCQ38855423-57635F05-EE12-43E7-884A-025AAA9E25FAQ39079514-95CC57B6-D15F-4790-ABBC-1A135E9B083BQ39307239-77092D51-4EFE-4AB9-8506-2B9F56CC8EC3Q39473352-74761CF1-0459-4B7C-AC29-ECC9F43374D1Q39696115-3003964A-2BB0-4332-92F0-7FA31F7C60D9Q40056035-C7D94753-32CA-440C-A4C2-BA32146DD83EQ40623679-4DB34C52-B9E6-4250-A2EF-057864AD2905Q42151148-7868E550-4BDD-4648-89EC-4ADD3940782AQ43132065-8233A71A-7B8A-44AF-9773-C50E3C17B67B
P2860
Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vpr cytopathicity independent ...... s type 1-infected CD4+ T cells
@ast
Vpr cytopathicity independent ...... s type 1-infected CD4+ T cells
@en
type
label
Vpr cytopathicity independent ...... s type 1-infected CD4+ T cells
@ast
Vpr cytopathicity independent ...... s type 1-infected CD4+ T cells
@en
prefLabel
Vpr cytopathicity independent ...... s type 1-infected CD4+ T cells
@ast
Vpr cytopathicity independent ...... s type 1-infected CD4+ T cells
@en
P2860
P356
P1433
P1476
Vpr cytopathicity independent ...... s type 1-infected CD4+ T cells
@en
P2093
Diane L Bolton
Michael J Lenardo
P2860
P304
P356
10.1128/JVI.00122-07
P407
P577
2007-06-06T00:00:00Z